Bone Biologics Corporation Revenue 2019–2020
Bone Biologics Corporation annual/quarterly revenue history and growth rate from 2019 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bone Biologics Corporation revenue for the quarter ending March 31, 2021 was 1.1 B, a 0.00% increase year-over-year.
- Bone Biologics Corporation annual revenue for 2020 was 1.1 B, a 0.00% increase from 2019.
- Bone Biologics Corporation annual revenue for 2019 was 1.1 B.
Bone Biologics Corporation (BBLG) — Frequently Asked Questions
Bone Biologics Corporation (BBLG) is a publicly traded US company. It has a market capitalization of $15M. In fiscal 2020 it reported revenue of $1.07B and net income of -$2M. Explore BBLG's stock price, financial statements, earnings history, margins and key ratios below.
What is Bone Biologics Corporation's market cap?
Bone Biologics Corporation (BBLG) has a market capitalization of $15M.
What is the BBLG stock price?
BBLG trades at $1.25 (+0.81% on the day).
How much revenue does Bone Biologics Corporation make?
Bone Biologics Corporation reported revenue of $1.07B in fiscal 2020.
Is BBLG profitable?
In fiscal 2020, Bone Biologics Corporation reported net income of -$2M.